Thalidomide for necrobiotic xanthogranuloma

Clin Exp Dermatol. 2022 Apr;47(4):769-770. doi: 10.1111/ced.15047. Epub 2021 Dec 29.

Authors

F R Ali¹, J T Lear^{1

2}

Affiliations

¹ East Cheshire Dermatology Service, Mid Cheshire NHS Foundation Trust, Macclesfield, UK.
² Dermatology Centre, University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, Manchester, UK.

PMID: 34856016
DOI: 10.1111/ced.15047

No abstract available

Publication types

Letter
Comment

MeSH terms

Dexamethasone
Humans
Necrobiotic Xanthogranuloma* / diagnosis
Necrobiotic Xanthogranuloma* / drug therapy
Thalidomide* / therapeutic use

Substances

Thalidomide
Dexamethasone